# CCTN - CLINICAL EVALUATION OF LONG ACTING REVERSIBLE CONTRACEPTIVES

> **NIH NIH N01** · OREGON HEALTH & SCIENCE UNIVERSITY · 2020 · $228,654

## Abstract

To evaluate contraceptive efficacy, pain of insertion, bleeding patterns, associate cramping, expulsion rates as well as other safety and side effects of the long acting reversible contraceptive (LARCs) in women of reproductive age.  The Contraceptive Discovery and Development Branch (CDDB) under the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) is committed to develop new methods that are long acting reversible contraceptives that can provide safe and effective contraception for women who may have risk factors against some contraceptive products as well as reduce the risk of venous thromboembolism (VTE).  The copper intrauterine devices (IUDs) are example of intrauterine systems that provide long acting contraceptive benefits without exogenous hormones or disruption of the regular menstrual cycle.

## Key facts

- **NIH application ID:** 10116212
- **Project number:** 275201300008I-P00003-27500006-1
- **Recipient organization:** OREGON HEALTH & SCIENCE UNIVERSITY
- **Principal Investigator:** ALISON EDELMAN
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $228,654
- **Award type:** —
- **Project period:** 2015-09-25 → 2022-09-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10116212

## Citation

> US National Institutes of Health, RePORTER application 10116212, CCTN - CLINICAL EVALUATION OF LONG ACTING REVERSIBLE CONTRACEPTIVES (275201300008I-P00003-27500006-1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10116212. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*